Literature DB >> 22790287

Magnetic resonance imaging-targeted prostate biopsy: back to the future.

Behfar Ehdaie, Shahrokh F Shariat.   

Abstract

Mesh：

Year:  2012        PMID： 22790287     DOI： 10.1016/j.eururo.2012.06.049

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  5 in total

1.  Validating multiparametric MRI for diagnosis and monitoring of prostate cancer in patients for active surveillance.

Authors:  Iqbal Sahibzada; Deepak Batura; Giles Hellawell
Journal:  Int Urol Nephrol       Date:  2016-01-12       Impact factor: 2.370

2.  Interstitial assessment of aggressive prostate cancer by physio-chemical photoacoustics: An ex vivo study with intact human prostates.

Authors:  Shengsong Huang; Yu Qin; Yingna Chen; Jing Pan; Chengdang Xu; Denglong Wu; Wan-Yu Chao; John T Wei; Scott A Tomlins; Xueding Wang; J Brian Fowlkes; Paul L Carson; Qian Cheng; Guan Xu
Journal:  Med Phys       Date:  2018-06-23       Impact factor: 4.071

3.  Prostate Cancer Gleason Score From Biopsy to Radical Surgery: Can Ultrasound Shear Wave Elastography and Multiparametric Magnetic Resonance Imaging Narrow the Gap?

Authors:  Cheng Wei; Yilong Zhang; Xinyu Zhang; Wael Ageeli; Magdalena Szewczyk-Bieda; Jonathan Serhan; Jennifer Wilson; Chunhui Li; Ghulam Nabi
Journal:  Front Oncol       Date:  2021-11-23       Impact factor: 6.244

4.  Quick identification of prostate cancer by wavelet transform-based photoacoustic power spectrum analysis.

Authors:  Shiying Wu; Ying Liu; Yingna Chen; Chengdang Xu; Panpan Chen; Mengjiao Zhang; Wanli Ye; Denglong Wu; Shengsong Huang; Qian Cheng
Journal:  Photoacoustics       Date:  2021-12-18

5.  Systematic 12- and 13-core transrectal ultrasound- or magnetic resonance imaging-guided biopsies significantly improve prostate cancer detection rate: A single-center 13-year experience.

Authors:  Gong Cheng; Yuan Huang; Bianjiang Liu; Ruizhe Zhao; Pengfei Shao; Jie Li; Chao Qin; Lixin Hua; Changjun Yin
Journal:  Oncol Lett       Date:  2014-07-15       Impact factor: 2.967
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.